PatternsRadar
Sign in

INDOCOIndoco Remedies Limited

NSE
Full chart
247.15INR+0.35 (+0.14%)Close · 6 Oct 2026
28 Jul 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹2,281 CrMarket cap
735.9P/E (TTM)
42.2%Delivery

Filings & corporate actions

78 results filed
CSV
Next results · Q2 FY27
Expected 19 Oct 2026 – 10 Nov 2026
Estimate: filed 19–41 days after quarter end, last 5 times
Dividend
₹0.20 per share · last 10 Sept 2026
2026
  • 10 SeptdividendDividend · ₹0.20 per share+10.0%
  • 28 JulresultsResults · Q1 FY27 · consolidated and standalone-8.1%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026-1.8%NSE
  • 7 MayresultsResults · Q4 FY26 · consolidated and standalone-9.1%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026-0.5%NSE
  • 3 FebresultsResults · Q3 FY26 · consolidated and standalone-3.8%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-2.5%NSE

Reaction to results · all yearsrose on day 0 in 31 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2728 Jul 2026-8.1%-9.9%-9.2%34.9×
Q4 FY267 May 2026-9.1%-10.3%-20.4%2.6×
Q3 FY263 Feb 2026-3.8%-12.6%-15.8%1.2×
Q2 FY266 Nov 2025-2.4%-1.4%-6.9%3.7×
Q1 FY2624 Jul 2025+3.4%+2.2%-10.2%13.8×
Q4 FY2522 May 2025+0.4%+3.3%+17.5%3.9×
Q3 FY2521 Jan 2025-15.8%-27.1%-28.3%9.5×
Q2 FY2524 Oct 2024-3.7%-0.5%-0.1%2.0×
Q1 FY2523 Jul 2024-2.0%0.0%+8.0%3.0×
Q4 FY2416 May 2024-0.5%-3.4%+1.4%1.3×
Q3 FY2423 Jan 2024-9.3%-8.4%-11.1%3.4×
Q2 FY2419 Oct 2023-5.3%-7.8%-1.0%1.7×
Q1 FY2425 Jul 2023-2.1%-4.5%+0.2%5.0×
Q4 FY2324 May 2023-0.1%+3.5%-3.5%1.1×
Q3 FY2325 Jan 2023-3.9%-7.0%-0.1%2.2×
Q2 FY2310 Nov 2022-2.5%+2.7%+8.4%1.0×
Q1 FY239 Aug 2022-5.0%-12.8%-8.4%1.8×
Q4 FY2217 May 2022+5.5%+9.3%+10.9%18.6×
Q3 FY221 Feb 2022+4.3%-4.6%+1.0%17.5×
Q2 FY222 Nov 2021-1.7%-6.2%-11.7%0.7×
Q1 FY2211 Aug 2021+17.6%+3.4%+3.4%22.2×
Q4 FY2125 May 2021-5.7%+4.4%+14.7%3.1×
Q3 FY219 Feb 2021-1.4%-7.9%-9.5%4.6×
Q2 FY216 Nov 2020-2.2%-2.3%+13.2%5.1×
Q1 FY2111 Aug 2020+4.0%+2.0%-12.2%10.1×
Q4 FY2024 Jun 2020-5.2%-7.1%-8.6%2.7×
Q3 FY2023 Jan 2020+2.6%-0.7%+17.3%2.7×
Q2 FY2031 Oct 2019+0.9%-4.1%+2.3%1.7×
Q1 FY2013 Aug 20190.0%-5.7%+9.9%4.3×
Q4 FY1929 May 2019+0.5%-8.2%-13.9%1.3×
Q3 FY1928 Jan 2019+3.2%-1.7%-5.0%3.1×
Q2 FY1927 Nov 2018+4.1%+4.2%+1.4%2.3×
Q1 FY1923 Aug 2018+0.4%+10.4%+0.8%0.5×
Q4 FY1829 Jun 2018-3.1%+1.1%+13.5%2.0×
Q3 FY1830 Jan 2018-0.6%-1.9%-6.6%0.3×
Q2 FY188 Nov 2017+1.0%+5.3%+3.9%0.3×
Q1 FY1821 Aug 2017-0.3%-2.3%+3.9%0.2×
Q4 FY178 Jun 2017-0.5%-2.7%+0.6%0.2×
Q3 FY1710 Feb 2017-2.3%-1.1%-6.0%0.2×
Q2 FY1726 Oct 2016-2.6%-5.7%-8.8%0.2×
Q1 FY173 Oct 2016-0.4%-1.7%-12.0%0.1×
Q4 FY1628 May 2016-0.6%-2.3%-3.1%0.5×
Q3 FY1630 Jan 2016-1.0%-6.7%-16.5%2.5×
Q2 FY162 Nov 2015+0.5%-8.5%-0.5%0.9×
Q1 FY1630 Jul 2015-10.7%-6.3%-11.5%11.2×
Q3 FY1531 Jan 2015+0.4%-3.7%-6.6%0.5×
Q2 FY1522 Oct 2014+1.9%+5.1%+7.8%0.2×
Q1 FY1530 Jul 2014+14.1%+22.1%+34.3%10.2×
Q4 FY141 Jul 2014+1.4%-0.1%+50.5%0.7×
Q3 FY1429 Jan 2014-2.8%+0.4%+5.1%2.0×
Q2 FY146 Nov 2013-5.3%+2.7%+11.9%2.5×
Q1 FY1430 Jul 2013-4.9%+0.2%-1.0%0.2×
Q4 FY1310 Jun 2013-0.5%-1.5%-0.6%0.5×
Q3 FY1329 Jan 2013-0.1%-0.8%+6.7%1.2×
Q2 FY132 Nov 2012+2.9%+6.1%+6.6%1.8×
Q1 FY1330 Jul 2012+0.8%+6.9%+19.9%0.2×
Q4 FY1229 May 2012+1.3%-2.2%-2.3%0.8×
Q3 FY1214 Feb 2012-0.1%-1.5%-4.3%1.2×
Q2 FY1221 Oct 2011-0.7%-3.1%+0.9%1.7×
Q1 FY1228 Jul 2011-4.1%-8.1%-13.7%7.4×
Q4 FY1127 Apr 2011+2.6%-2.5%-3.0%3.3×
Q3 FY1120 Jan 2011-4.8%-4.6%-16.1%3.7×
Q2 FY1120 Oct 2010+4.4%+6.8%+7.2%6.4×
Q1 FY1122 Jul 2010-8.2%-15.8%-11.7%4.9×
Q4 FY1026 Apr 2010+1.1%+5.8%-5.1%1.1×
Q3 FY1027 Jan 2010+2.1%+4.1%-4.7%3.4×
Q2 FY1030 Oct 2009+0.4%+1.2%+8.5%0.7×
Q1 FY1030 Jul 2009-0.8%+1.2%+12.8%0.5×
Q4 FY0929 Apr 2009+0.3%-5.7%+17.3%0.8×
Q3 FY0930 Jan 20090.0%+1.0%+0.6%0.3×
Q2 FY0931 Oct 2008-1.4%-1.8%-20.3%0.5×
Q1 FY0930 Jul 2008+6.8%+8.9%-0.7%22.3×
Q4 FY0830 Apr 2008+4.3%-3.3%-8.5%4.4×
Q3 FY0829 Jan 20080.0%+2.8%+6.0%0.3×
Q2 FY0831 Oct 2007+8.6%+2.9%+11.5%9.0×
Q1 FY0818 Oct 2007-1.2%+1.6%-0.3%3.0×
Q4 FY0726 Apr 2007+3.9%+1.1%+7.0%4.7×
Average-0.5%-1.5%+0.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+6.8%
Profit YoY—
Interest cost YoY—
Revenue QoQ-1.7%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open248.15
Day range244.50 – 249.95
52-week range162.19 – 317.35
From 52w high-22.1%
RSI (14)48.8
ATR (14)15.10
Volume1.68L
Avg volume (20D)18.05L
Rel volume0.09×
Volatility (1Y)49.2%
Turnover₹4.2Cr
SMA 50 / 200239.18 / 222.62

Delivery percentage

Latest · 6 Oct 202642.2%
20-day avg33.9%
1-year avg48.5%
Percentile (own history)27th
Range3.4–99.0%
Sessions1,731

Over the last 20 sessions INDOCO settled 33.9% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 48.5%, so recent sessions are running 14.6 points lower than usual. The latest session ranks higher than 27% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.14%-0.77%-9.32%+2.71%+31.97%-13.52%

Valuation

CSV
Market cap₹2,281 Cr
P/E (TTM)735.9
EPS (TTM)0.34
Shares outstanding9.23Cr
Listed14 Jan 2005

Ownership

CSV
Promoter58.86%
Promoter Δ QoQ0.00 pp
Public41.00%
FII1.27%
DII17.68%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)484.7445.4475.6467.5
YoY chg——+21.9%+6.8%
Net profit (₹ Cr)(9.2)(29.5)(23.7)65.4
YoY chg————
Net margin-1.9%-6.6%-5.0%14.0%
EPS-1.00-3.19-2.567.09

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 58.86% · public 41.00%
30 Sept 2021: promoter 58.69%31 Dec 2021: promoter 58.69%31 Mar 2022: promoter 58.69%30 Jun 2022: promoter 58.69%30 Sept 2022: promoter 58.69%31 Dec 2022: promoter 58.69%31 Mar 2023: promoter 58.69%30 Jun 2023: promoter 58.73%30 Sept 2023: promoter 58.74%31 Dec 2023: promoter 58.74%31 Mar 2024: promoter 58.72%30 Jun 2024: promoter 58.75%30 Sept 2024: promoter 58.75%31 Dec 2024: promoter 58.80%31 Mar 2025: promoter 58.90%30 Jun 2025: promoter 58.90%30 Sept 2025: promoter 58.90%31 Dec 2025: promoter 58.90%31 Mar 2026: promoter 58.86%30 Jun 2026: promoter 58.86%
2021-092026-06
  • Promoter
  • Public and others
Promoter
58.86%
Public
41.00%
Promoter change
0.00 pp
Filed
17 Jul 2026
FII
1.27%
DII
17.68%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations481.7459.4449.6431.5432.7410.6390.2437.9484.7445.4475.6467.5
Other income4.42.42.71.01.60.92.01.60.81.0(0.0)2.2
Total income486.2461.8452.3432.5434.2411.4392.2439.5485.4446.3475.6469.7
Total expenses439.9430.9439.1425.6439.1443.4437.8476.2498.4471.5504.3489.3
└ Finance costs8.110.112.114.317.816.118.026.124.625.645.928.3
└ Depreciation21.424.426.227.528.828.728.829.732.332.032.534.5
Profit before tax46.322.633.07.0(4.8)(31.0)(45.5)(36.7)(13.5)(31.3)(25.0)77.7
Tax expense11.07.111.05.25.2(2.6)(4.2)(0.3)(4.3)(1.9)(1.3)12.3
Net profit35.215.622.01.8(10.0)(28.4)(41.3)(36.4)(9.2)(29.5)(23.7)65.4
EPS3.821.692.390.20-1.09-3.08-4.48-3.94-1.00-3.20-2.577.09
Net margin7.32%3.39%4.90%0.42%-2.31%-6.92%-10.59%-8.30%-1.90%-6.61%-4.98%14.00%
PBT margin9.61%4.93%7.33%1.62%-1.12%-7.54%-11.67%-8.37%-2.79%-7.03%-5.26%16.62%
Tax rate23.85%31.24%33.20%73.89%———————15.80%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 28 Jul 2026.

INDOCO at a glance

  • INDOCO closed at ₹247.15 on 6 Oct 2026, +0.14% on the day, -13.5% over one year, 22.1% below its 52-week high of ₹317.35.
  • Delivery was 42.2% of traded quantity on 6 Oct 2026, the 27th percentile of its own 1,731 sessions with a reading (20-session average 33.9%, 1-year average 48.5%).
  • Market capitalisation is ₹2,281 crore at a trailing P/E of 735.9 (trailing EPS ₹0.34).
  • Q1 FY27 results (consolidated, filed 28 Jul 2026): revenue ₹468 crore (+6.8% year on year), net profit ₹65 crore; the price moved -8.1% on the first session after.
  • Promoters held 58.86% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 19 Oct 2026 and 10 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE873D01024
SeriesEQ
Listed14 Jan 2005
History from14 Jan 2005
Sessions5,382
Turnover rank#492

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE